Please ensure Javascript is enabled for purposes of website accessibility



We have the knowledge and expertise to handle the most demanding and complex transactions and provide expert, efficient and cost effective services to all our clients. Our commercial understanding and experience of working with leading financial institutions, professional advisers and regulatory bodies enable us to add real value to our clients’ businesses.

View all services


Our experts provide independent guidance spanning advice and training to implementation and evaluation across sustainable investing, regulatory compliance and tech. Our tailored advice meets clients' specific needs, delivering flexible solutions and support.

View all Consulting


Our sector approach relies on smart collaboration between our business divisions, our service lines and our jurisdictions. These sector-based teams have a deep understanding of related businesses and industry dynamics. The specific combination of our highly informed experts helps our clients see around corners.

View all sectors


Ogier provides practical advice on BVI, Cayman Islands, Guernsey, Irish, Jersey and Luxembourg law through our global network of offices across the Asian, Caribbean and European timezones. Ogier is the only firm to advise on this unique combination of laws.

News and insights

Keep up to date with industry insights, analysis and reviews. Find out about the work of our expert teams and subscribe to receive our newsletters straight to your inbox.

Fresh thinking, sharper opinion.

About us

We get straight to the point, managing complexity to get to the essentials. Our global network of offices covers every time zone. 

No Content Set

Ogier advises Bull Horn Holdings SPAC on US$175 million merger with Coeptis Therapeutics


03 November 2022

British Virgin Islands


Ogier has acted as British Virgin Islands counsel to Nasdaq-listed SPAC Bull Horn Holdings Corp in its merger with Coeptis Therapeutics, a biopharmaceutical company that develops innovative cell therapy technologies for cancer.

The deal, valued at around US$175 million, was originally signed in April 2022 and closed on 27 October 2022 following the approval of Bull Horn's shareholders, who now hold approximately 12% of the equity of the combined company, with the balance being held by Coeptis' former stockholders.

For this transaction, the Ogier team was led by partner Michael Killourhy and included managing associate David Mathews.

Speaking about the transaction, Michael said, "We have advised Bull Horn since their US$75 million IPO in November 2020 and it was a pleasure to work with them on their business combination. Ogier has successfully completed a number of these transactions recently and our BVI SPAC practice continues to go from strength to strength."

Bull Horn was advised in the US by Ellenoff Grossman & Schole LLP, with Meister Seelig & Fein LLP advising Coeptis.


No Content Set